down arrow

Inspire Medical Systems, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4577301090
USD
140.03
5.28 (3.92%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

132.39142.56

52 Week

70.77216.01
Valuation
Technical
Day's Volume

CASH

1.5 M

Shareholding (Mar 2025)

FII

21.12%

Held by 221 FIIs

DII

0

Held by 88 DIIs

Promoter

4.62%

How big is Inspire Medical Systems, Inc.?

22-Jun-2025

As of Jun 18, Inspire Medical Systems, Inc. has a market capitalization of $3.75 billion, with net sales of $840.11 million and a net profit of $66.50 million over the latest four quarters. The company's shareholder's funds are $689.70 million, and total assets amount to $808.38 million.

Market Cap: As of Jun 18, Inspire Medical Systems, Inc. has a market capitalization of 3,753.10 million, categorizing it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Inspire Medical Systems reported net sales of 840.11 million and a net profit of 66.50 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company's shareholder's funds amounted to 689.70 million, while total assets were reported at 808.38 million.

Read More

What does Inspire Medical Systems, Inc. do?

22-Jun-2025

Inspire Medical Systems, Inc. is a mid-cap medical technology company that develops minimally invasive solutions for obstructive sleep apnea. As of March 2025, it reported net sales of $201 million and a net profit of $3 million.

Overview:<BR>Inspire Medical Systems, Inc. is a medical technology company focused on developing and commercializing minimally invasive solutions for patients with obstructive sleep apnea, operating within the Pharmaceuticals & Biotechnology industry and classified as a mid-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 201 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 3 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 3,753.10 Million (Mid Cap)<BR><BR>Key Metrics:<BR>P/E: 60.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.58 <BR>Return on Equity: 10.46% <BR>Price to Book: 5.90 <BR><BR>Contact Details:<BR>Address: 5500 Wayzata Blvd Ste 1600, GOLDEN VALLEY MN: 55416-1237 <BR>Tel: 1 763 9575037 <BR>Website: http://www.inspiremedicalsystems.com

Read More

Who are in the management team of Inspire Medical Systems, Inc.?

22-Jun-2025

As of March 2022, the management team of Inspire Medical Systems, Inc. includes Marilyn Nelson (Independent Chairman), Timothy Herbert (CEO), and directors Shelley Broader, Georgia Garinois-Melenikiotou, Gary Ellis, Jerry Griffin, and Shawn McCormick. They are responsible for the company's strategic direction and operations.

As of March 2022, the management team of Inspire Medical Systems, Inc. includes the following individuals:<BR><BR>- Ms. Marilyn Nelson, Independent Chairman of the Board<BR>- Mr. Timothy Herbert, President, Chief Executive Officer, and Director<BR>- Ms. Shelley Broader, Director<BR>- Ms. Georgia Garinois-Melenikiotou, Director<BR>- Mr. Gary Ellis, Independent Director<BR>- Dr. Jerry Griffin, Independent Director<BR>- Mr. Shawn McCormick, Independent Director<BR><BR>This team oversees the strategic direction and operations of the company.

Read More

Is Inspire Medical Systems, Inc. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, Inspire Medical Systems, Inc. is considered overvalued with a valuation grade of fair, reflected by a high P/E ratio of 60 and significant underperformance of -60.44% over the past year compared to the S&P 500's 14.08%.

As of 17 October 2025, the valuation grade for Inspire Medical Systems, Inc. has moved from attractive to fair. The company appears to be overvalued based on its current financial metrics. Key ratios include a P/E ratio of 60, an EV to EBITDA of 62.23, and a PEG ratio of 0.12, which suggests that the stock is priced high relative to its earnings growth potential.<BR><BR>In comparison to its peers, Inspire Medical Systems has a P/E ratio significantly higher than QIAGEN NV at 24.20 and Bio-Rad Laboratories, Inc. at 16.20, both of which are considered fair. Additionally, while Inspire's PEG ratio is low at 0.12, indicating potential undervaluation in terms of growth, the overall high valuation ratios suggest it is not justified at the current price level. Over the past year, Inspire Medical Systems has underperformed significantly, with a return of -60.44% compared to the S&P 500's 14.08%, reinforcing the notion that the stock may be overvalued.

Read More

Is Inspire Medical Systems, Inc. technically bullish or bearish?

28-Oct-2025

As of October 24, 2025, Inspire Medical Systems, Inc. has shifted to a bearish trend, supported by negative signals from moving averages, KST, and Bollinger Bands, while underperforming the S&P 500 with a year-to-date return of -58.18%.

As of 24 October 2025, the technical trend for Inspire Medical Systems, Inc. has changed from mildly bearish to bearish. The current stance is bearish, with key indicators supporting this view including a bearish signal from the daily moving averages, as well as bearish readings from the KST and Bollinger Bands on both weekly and monthly time frames. The MACD shows a conflicting mildly bullish signal on the weekly but is bearish on the monthly, indicating weakness in the longer-term trend. Additionally, the stock has significantly underperformed the S&P 500, with a year-to-date return of -58.18% compared to the S&P 500's 15.47%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROE of 2.09%

  • The company has been able to generate a Return on Equity (avg) of 2.09% signifying low profitability per unit of shareholders funds
2

With ROE of 10.46%, it has a attractive valuation with a 6.31 Price to Book Value

3

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 2,471 Million (Small Cap)

stock-summary
P/E

60.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.44

stock-summary
Return on Equity

8.43%

stock-summary
Price to Book

3.65

Revenue and Profits:
Net Sales:
217 Million
(Quarterly Results - Jun 2025)
Net Profit:
-4 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
62.22%
0%
62.22%
6 Months
1.54%
0%
1.54%
1 Year
-28.89%
0%
-28.89%
2 Years
-10.35%
0%
-10.35%
3 Years
-41.53%
0%
-41.53%
4 Years
-32.54%
0%
-32.54%
5 Years
-30.15%
0%
-30.15%

Inspire Medical Systems, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Inspire Medical Systems Experiences Revision in Stock Evaluation Amid Market Challenges

Inspire Medical Systems Experiences Revision in Stock Evaluation Amid Market Challenges

Inspire Medical Systems, Inc. has experienced significant challenges, with its stock price declining nearly 60% over the past year, contrasting sharply with the S&P 500's positive performance. Technical indicators show mixed signals, reflecting ongoing difficulties and the need for strategic adjustments in the current market landscape.

Read More

Is Inspire Medical Systems, Inc. technically bullish or bearish?

As of 24 October 2025, the technical trend for Inspire Medical Systems, Inc. has changed from mildly bearish to bearish. The current stance is bearish, with key indicators supporting this view including a bearish signal from the daily moving averages, as well as bearish readings from the KST and Bollinger Bands on both weekly and monthly time frames. The MACD shows a conflicting mildly bullish signal on the weekly but is bearish on the monthly, indicating weakness in the longer-term trend. Additionally, the stock has significantly underperformed the S&P 500, with a year-to-date return of -58.18% compared to the S&P 500's 15.47%....

Read More

Is Inspire Medical Systems, Inc. technically bullish or bearish?

As of 24 October 2025, the technical trend for Inspire Medical Systems, Inc. has changed from mildly bearish to bearish. The current stance is bearish, with key indicators supporting this view including a bearish daily moving average, bearish weekly Bollinger Bands, and bearish KST across both weekly and monthly time frames. The MACD shows a mildly bullish signal on the weekly but is bearish on the monthly, indicating some short-term strength that is overshadowed by longer-term weakness. The Dow Theory reflects a mildly bullish weekly stance but is also mildly bearish monthly. Overall, the bearish indicators dominate, suggesting a weak technical outlook. Multi-period return data is not available for comparison with the S&P 500....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
60.33%
EBIT Growth (5y)
22.19%
EBIT to Interest (avg)
-15.13
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.58
Sales to Capital Employed (avg)
1.11
Tax Ratio
7.59%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
3.71%
ROE (avg)
2.09%
Valuation key factors
Factor
Value
P/E Ratio
60
Industry P/E
Price to Book Value
6.31
EV to EBIT
73.16
EV to EBITDA
62.23
EV to Capital Employed
13.57
EV to Sales
4.34
PEG Ratio
0.12
Dividend Yield
NA
ROCE (Latest)
18.55%
ROE (Latest)
10.46%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 130 Schemes (81.0%)

Foreign Institutions

Held by 221 Foreign Institutions (21.12%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 10.82% vs 29.65% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -136.73% vs 181.67% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "217.10",
          "val2": "195.90",
          "chgp": "10.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.10",
          "val2": "6.50",
          "chgp": "-98.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.60",
          "val2": "9.80",
          "chgp": "-136.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-15.30%",
          "val2": "26.00%",
          "chgp": "-4.13%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 28.49% vs 53.17% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 352.36% vs 52.78% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "802.80",
          "val2": "624.80",
          "chgp": "28.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "42.60",
          "val2": "-37.40",
          "chgp": "213.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "53.50",
          "val2": "-21.20",
          "chgp": "352.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "44.90%",
          "val2": "-64.50%",
          "chgp": "10.94%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
217.10
195.90
10.82%
Operating Profit (PBDIT) excl Other Income
0.10
6.50
-98.46%
Interest
0.00
0.00
Exceptional Items
-4.00
0.00
Consolidate Net Profit
-3.60
9.80
-136.73%
Operating Profit Margin (Excl OI)
-15.30%
26.00%
-4.13%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 10.82% vs 29.65% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -136.73% vs 181.67% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
802.80
624.80
28.49%
Operating Profit (PBDIT) excl Other Income
42.60
-37.40
213.90%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
53.50
-21.20
352.36%
Operating Profit Margin (Excl OI)
44.90%
-64.50%
10.94%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 28.49% vs 53.17% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 352.36% vs 52.78% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Inspire Medical Systems, Inc. stock-summary
stock-summary
Inspire Medical Systems, Inc.
Pharmaceuticals & Biotechnology
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the developing and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. The Company has developed a novel, closed-loop solution that continuously monitors a patient's breathing patterns and delivers mild hypoglossal nerve stimulation to maintain an open airway. The system delivers mild stimulation to the hypoglossal nerve, which controls the movement of user's tongue and other key airway muscles. By stimulating these muscles, the airway remains open during sleep. The system is controlled by a small handheld sleep remote.
Company Coordinates stock-summary
Company Details
5500 Wayzata Blvd Ste 1600 , GOLDEN VALLEY MN : 55416-1237
stock-summary
Tel: 1 763 9575037
stock-summary
http://www.inspiremedicalsystems.com
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."